Member Info for Pingu777

And as painful as it is can people stop talking share prices and actual market cap with short and longer term targets.

The dilution is done. The company market cap is the true indicator of value. The share price is led completely by the market cap.

Maybe the SP will go up now George unlike with MINT. Maybe HEMO has news they’ll happily release now. We’re due progress updates on so many fronts it’s ridiculous.

Remains the most undervalued junior pharma (soon to be clinical) on the market.

Lots of dilution yes. Shareholders like me are readily and understandably ****ed off. But the potential growth from here is significant.

LTH have to stay patient and bite the bullet hopefully with realistic timescales of investment. New investors are lucky lucky people.

Should be a good week. Fingers crossed.

What are these rumours of an RNS tomorrow based on? Anyone know?

Hope you all got HEMO at 2.2p

Next RNS about CLNs. Followed by some good stuff over next few weeks.

I’ve felt the pain, now show some gains!!!

How about you can ask whatever you like? You must be a hoot at parties.

I know what the company market cap is now.

I value potential and IP even if others don’t and see a serious gap between current and fair value.

The market will correct soon enough in my opinion. Obviously the CLNs have to be addressed for this to happen.

I value HEMO at more than £40m with the partnerships and portfolio of products and closeness to clinical trials.

Clearly, we’re a long way off. There has to be further dilution to fund the progress of projects. I hope the BOD address the CLNs soon and give us a platform to begin providing more positive updates.

HEMO

Then we might see some actual news flow

I know!!! Same here!! They messed up big time with the RNS style and the CLNs. They need to fix it for all investors.

Hopefully the silence is due to the amount of work going into sorting the finance debacle.

Not a lot to say is there after this debacle. Just have to trust the BOD are working hard to turn things around for us after digging us into this hole. Hang in there people.

*Pre clinical pharma :-)

We have been a ridiculously low burn pre pharma that’s ticked over on peanuts and raised bugger all compared to most. If the deal hasn’t landed by the accounts then a Vlad pay rise tells me only one thing... deal done

CJ worrying about legal fees, a true sniffer of priorities
Pumper still trying to work out what HEMO do and if he should buy back... again...
Pawnking... we just need to employ more staff?!

If we’re employing more staff right now then HEMO aren’t offloading CDX to Eli. I’d prefer it’s off our expenses list and we can focus on SAFE HEMO CAR T and the CBR platform ... (which is incidentally born from the COVID work pumper)

Try meet the team Pawnking on the HEMO website.

Sir Marc CEO and an adviser to Vlad. He is not an active scientist at HEMO or involved in any other day to day activities. It’s a strategic position.

I’d have probably looked into that one a bit sooner than now Pumpky.

Yeah you’re right CJ, everyone’s desperate to see the accounts for the pre clinical pharma who doesn’t make any money yet but with a Big pharma deal imminent. Top of everyone’s list those accounts.

But whilst we’re on the point I’ll be interested to see the focus on the forward looking statements and the views of Sir Marc Feldmann.

Possibly, dhub apologies